Misclassification Matters: A Case for Utilization of Histologic Coding in UK Biobank Analyses.

Area of Science:

• Epidemiologic Research
• Cancer Epidemiology
• Bioinformatics

Background:

• Misclassification and measurement error pose significant challenges in epidemiologic studies.
• Large datasets, such as the UK Biobank, are susceptible to coding inaccuracies.
• Pancreatic neuroendocrine neoplasms are frequently misclassified as exocrine pancreatic cancer.

Purpose of the Study:

• To examine the prevalence of misclassification of pancreatic neoplasms in published literature.
• To highlight the impact of coding errors on exocrine pancreatic cancer research.
• To advocate for improved coding practices in large-scale biobank studies.

Main Methods:

• Review of existing literature on pancreatic cancer case ascertainment in large datasets.
• Analysis of International Classification of Diseases (ICD) coding practices.
• Evaluation of the utility of International Classification of Diseases for Oncology, Third Edition (ICD-O-3) for histologic classification.

Main Results:

• Studies relying solely on ICD codes often misclassify pancreatic neuroendocrine neoplasms as exocrine pancreatic cancer.
• This misclassification can significantly impact the validity and reliability of research findings.
• ICD-O-3 histologic coding offers a more precise method for distinguishing between pancreatic tumor types.

Conclusions:

• Rigorous and consistent application of histologic coding practices, such as ICD-O-3, is essential for accurate pancreatic cancer research.
• Implementing improved coding standards in the UK Biobank and similar resources will enhance data integrity.
• Accurate case definition is critical for advancing our understanding of exocrine pancreatic cancer.